AR and prostate cancer: To gain experimental support for RNA secondary structure models, we employed targeted DMS-MaPseq (51) in 22Rv1 cells to analyze both the longest isoform, AR-FL (FL), as well as the prostate cancer-associated truncated isoform, AR-V7 (V7).